Entity Details

Primary name NAXE
Entity type gene
Source Source Link

Details

PrimaryID128240
RefseqGeneNG_052542
SymbolNAXE
NameNAD(P)HX epimerase
Chromosome1
Location1q22
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate2001-11-30
ModificationDate2021-06-22

Ontological Relatives

UniProt IDsNNRE_HUMAN

GO terms

Show/Hide Table
GOName
GO:0000166 nucleotide binding
GO:0002040 sprouting angiogenesis
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005739 mitochondrion
GO:0005759 mitochondrial matrix
GO:0006869 lipid transport
GO:0010874 regulation of cholesterol efflux
GO:0016525 negative regulation of angiogenesis
GO:0031580 membrane raft distribution
GO:0034356 NAD biosynthesis via nicotinamide riboside salvage pathway
GO:0046496 nicotinamide nucleotide metabolic process
GO:0046872 metal ion binding
GO:0052856 NADHX epimerase activity
GO:0052857 NADPHX epimerase activity
GO:0070062 extracellular exosome

Diseases

Show/Hide Table
Disease IDSourceNameDescription
617186 OMIMEncephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 1 (PEBEL1)An autosomal recessive severe neurometabolic disorder characterized by severe leukoencephalopathy usually associated with a trivial febrile illness. Affected infants tend to show normal early development followed by acute psychomotor regression with ataxia, hypotonia, respiratory insufficiency, and seizures. Disease course is rapidly progressive, leading to coma, global brain atrophy, and death in the first years of life. Brain imaging shows multiple abnormalities, including brain edema and signal abnormalities in the cortical and subcortical regions. The disease is caused by variants affecting the gene represented in this entry.